Publications

5803 Results

Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set [PMID:18467725]

Authors
MJ O'Connell;ME Campbell;R Goldberg;A Grothey;J Seitz;JK Benedetti;T Andre;DG Haller;DJ Sargent
Journal / Conference
Journal of Clinical Oncology 26(14):2336-2341
Year
2008
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415)

Summary report 7th annual targeted therapies of the treatment of lung cancer [PMID18449013;PMC3374724]

Authors
L Einhorn;P Bonomi;P Bunn;ER Camidge;DP Carbone;H Choy;S Dubinett;D Gandara;L Gaspar;R Govindan;DH Johnson;J Minna;G Scagliotti;H West;R Herbst
Journal / Conference
Journal of Thoracic Oncology 3:545-555
Year
2008
Research Committee(s)
Lung
Study Number(s)
S0023, S0342, S0533

Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen [PMID 18332475]

Authors
PE Goss;J Ingle;JL Pater;S Martino;NJ Robert;HB Ross;MJ Piccart;M Castiglione;LE Shepherd;KI Pritchard;RB Livingston;NE Davidson;L Norton;EA Perez;J Abrams;DA Cameron;MJ Palmer;D Tu
Journal / Conference
Journal of Clinical Oncology 26(12):1948-1955
Year
2008
Research Committee(s)
Breast
Study Number(s)
JMA17

Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704 [PMID19029412; PMC2645109]

Authors
AC Berger;M Garcia;JP Hoffman;WF Regine;RA Abrams;H Safran;A Konski;A Benson;J Macdonald;CG Willett
Journal / Conference
Journal of Clinical Oncology 26(36):5918-5922
Year
2008
Research Committee(s)
Gastrointestinal
Study Number(s)
R9704

Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17

Authors
H Muss;J Ingle;S Martino;N Robert;J Pater;T Whelan;M Palmer;M Piccart;L Shepherd;Z He;P Goss
Journal / Conference
Journal of Clinical Oncology, 26(12):1956-1964
Year
2008
Research Committee(s)
Breast
PMID
PMID18332474
PMC
n/a
Study Number(s)
JMA17

Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17 [PMID18332043]

Authors
J Ingle;D Tu;J Pater;H Muss;S Martino;N Robert;M Piccart;M Castiglione;L Shepherd;K Pritchard;R Livingston;N Davidson;L Norton;EA Perez;J Abrams;D Cameron;M Palmer;P Goss
Journal / Conference
Annals of Oncology 19(5):877-882
Year
2008
Research Committee(s)
Breast
Study Number(s)
JMA17

Concurrent doxorubicin plus docetaxel is not more effective than concurrent doxorubicin plus cyclophosphamide in operable breast cancer with 0 to 3 positive axillary nodes: North American Breast Cancer Intergroup Trial E 2197

Authors
L Goldstein;A O'Neill;J Sparano;E Perez;L Shulman;S Martino;NE Davidson
Journal / Conference
Journal of Clinical Oncology 26(25):4092-4099
Year
2008
Research Committee(s)
Breast
PMID
PMID18678836
PMC
PMC2654376
Study Number(s)
E2197

Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features

Authors
L Goldstein;R Gray;S Bavde;B Childs;C Yoshizawa;S Rowley;S Shak;FL Baehner;P Ravdin;NE Davidson;GW Sledge;E Perez;L Shulman;S Martino;J Sparano
Journal / Conference
Journal of Clinical Oncology 26(25):4063-4071
Year
2008
Research Committee(s)
Breast
PMID
PMID18678838
PMC
PMC2654377
Study Number(s)
E2197

Evaluation of the combination of docetaxel/carboplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN): A Southwest Oncology Group phase II study [PMID: 17530488]

Authors
WE Samlowski;J Moon;JP Kuebler;CR Nichols;DR Gandara;H Ozer;SK Williamson;JN Atkins;DE Schuller;JF Ensley
Journal / Conference
Cancer Investigation 25:182-188
Year
2007
Research Committee(s)
Head and Neck
Study Number(s)
S9902

Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500) [PMID17696203]

Authors
SH Petersdorf;C Rankin;DR Head;HR Terebelo;CL Willman;SP Balcerzak;AB Karnad;SR Dakhil;FR Appelbaum
Journal / Conference
American Journal of Hematology 82:1056-1062
Year
2007
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9500